 Elanco Animal Health Inc NYSE: ELAN said on Wednesday it will acquire Kindred Biosciences Inc NASDAQ: KIN for roughly 440 million 312 million to expand its footprint in the pet health industry. The acquisition will bring three potential dermatology blockbusters, which are currently in the development phase, under Elancos umbrella. 